SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-026738
Filing Date
2019-07-30
Accepted
2019-07-30 07:46:42
Documents
13
Period of Report
2019-07-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alks-8k_20190730.htm   iXBRL 8-K 39952
2 EX-99.1 alks-ex991_7.htm EX-99.1 42181
  Complete submission text file 0001564590-19-026738.txt   225071

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alks-20190730.xsd EX-101.SCH 6201
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alks-20190730_lab.xml EX-101.LAB 19750
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alks-20190730_pre.xml EX-101.PRE 12180
6 EXTRACTED XBRL INSTANCE DOCUMENT alks-8k_20190730_htm.xml XML 3531
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 19983209
SIC: 2834 Pharmaceutical Preparations